Breaking News Instant updates and real-time market news.

WLH

William Lyon Homes

$17.11

-0.13 (-0.75%)

07:28
08/13/19
08/13
07:28
08/13/19
07:28

William Lyon Homes upgraded to Outperform on valuation at Wedbush

As previously reported, Wedbush analyst Jay McCanless upgraded William Lyon Homes to Outperform from Neutral and raised his price target on the shares to $21 from $20. The analyst believes the recent pullback in shares has "effectively discounted" the reduction in his 2019 EPS estimates following the Q2 results. Overall, he views the shares as undervalued at current levels.

WLH William Lyon Homes
$17.11

-0.13 (-0.75%)

09/20/18
WEDB
09/20/18
DOWNGRADE
Target $22
WEDB
Neutral
William Lyon Homes downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Jay McCanless downgraded William Lyon Homes to Neutral from Outperform and cut his price target to $22 from $35. In a research note to investors, McCanless estimated the company's exposure to Seattle and California at just under 50% of the company's community count, and says both markets have exhibited a rapid slowdown in unit sales and in home price appreciation. He does not see a near-term positive catalyst to reverse either trend.
11/28/18
JPMS
11/28/18
NO CHANGE
JPMS
JPMorgan remains cautious on Homebuilders after new home sales miss
JPMorgan analyst Michael Rehaut remains cautious on Homebuilding stocks after October new home sales fell 9%, below the Street's estimate of 4%. The analyst expects a "fairly tepid" recovery in housing starts to continue in 2019 and believes the current softness may last for a few more months. Further, he thinks builder fundamentals will moderate over the next two years. His Overweight-rated builders include Lennar (LEN), LGI Homes (LGIH) and William Lyon Homes (WLH). His Overweight-rated names in building products include Masonite (DOOR), Fortune Brands (FBHS) and Stanley Black & Decker (SWK).
12/19/18
ZELM
12/19/18
NO CHANGE
ZELM
William Lyon Homes removed from Top Idea Basket as a Buy at Zelman
08/13/19
WEDB
08/13/19
UPGRADE
WEDB
Outperform
William Lyon Homes upgraded to Outperform from Neutral at Wedbush

TODAY'S FREE FLY STORIES

PCG

PG&E

$14.30

-0.08 (-0.56%)

06:44
08/19/19
08/19
06:44
08/19/19
06:44
Periodicals
PG&E holds on to sole rights to devise chapter 11 exit plan, WSJ reports »

A U.S. Bankruptcy Court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVGO

Livongo Health

$37.00

3.22 (9.53%)

06:42
08/19/19
08/19
06:42
08/19/19
06:42
Initiation
Livongo Health initiated  »

Livongo Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

ACM

Aecom

$32.97

0.53 (1.63%)

06:38
08/19/19
08/19
06:38
08/19/19
06:38
Upgrade
Aecom rating change  »

Aecom upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:37
08/19/19
08/19
06:37
08/19/19
06:37
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

NYNY

Empire Resorts

$8.35

-0.145 (-1.71%)

06:37
08/19/19
08/19
06:37
08/19/19
06:37
Hot Stocks
Empire Resorts to be acquired by Kien Huat, Genting Malaysia for $9.74 per share »

Empire Resorts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DECK

Deckers Brands

$134.33

1.39 (1.05%)

06:36
08/19/19
08/19
06:36
08/19/19
06:36
Upgrade
Deckers Brands rating change  »

Deckers Brands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 25

    Sep

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:35
08/19/19
08/19
06:35
08/19/19
06:35
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:33
08/19/19
08/19
06:33
08/19/19
06:33
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:32
08/19/19
08/19
06:32
08/19/19
06:32
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:31
08/19/19
08/19
06:31
08/19/19
06:31
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

WLL

Whiting Petroleum

$8.61

0.36 (4.36%)

06:30
08/19/19
08/19
06:30
08/19/19
06:30
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

ARCC

Ares Capital

$18.63

0.27 (1.47%)

06:29
08/19/19
08/19
06:29
08/19/19
06:29
Upgrade
Ares Capital rating change  »

Ares Capital upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTVA

Corteva

$30.25

1.84 (6.48%)

06:26
08/19/19
08/19
06:26
08/19/19
06:26
Upgrade
Corteva rating change  »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.42

0.78 (0.43%)

, ACN

Accenture

$193.19

3.675 (1.94%)

06:25
08/19/19
08/19
06:25
08/19/19
06:25
Periodicals
Facebook content moderation firm sought counseling details, The Intercept says »

A Facebook (FB) content…

FB

Facebook

$183.42

0.78 (0.43%)

ACN

Accenture

$193.19

3.675 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Oct

PROS

ProSight

$18.71

-0.5 (-2.60%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Initiation
ProSight initiated  »

ProSight initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$206.44

4.71 (2.33%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Periodicals
Apple CEO Cook has met Trump 'at least' 5 times in a year, BI reports »

Apple CEO Tim Cook has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$31.01

0.73 (2.41%)

06:21
08/19/19
08/19
06:21
08/19/19
06:21
Earnings
PolyOne raises FY19 adj. EPS view to up 6%-8% from up 4%-6%, consensus $2.54 »

Guidance reflects the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

06:20
08/19/19
08/19
06:20
08/19/19
06:20
Periodicals
Amazon beats IRS appeal in U.S. tax dispute, Reuters reports »

Amazon on Friday defeated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ARMK

Aramark

$37.07

-0.07 (-0.19%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Upgrade
Aramark rating change  »

Aramark upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.95

4.74 (2.38%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Downgrade
Amgen rating change  »

Amgen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

POL

PolyOne

$31.01

0.73 (2.41%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Hot Stocks
PolyOne to sell PP&S business to SK Capital Partners for $775M in cash »

PolyOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CNHI

CNH Industrial

$8.82

0.18 (2.08%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Upgrade
CNH Industrial rating change  »

CNH Industrial upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$7.74

0.19 (2.52%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
EnLink Midstream rating change  »

EnLink Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 06

    Nov

HEP

Holly Energy Partners

$27.48

0.31 (1.14%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$89.46

0.91 (1.03%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Periodicals
Novartis to respond to demand for data manipulation details, Reuters says »

Novartis plans to answer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.